Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe record history now shows a new revision, v3.5.4, as the latest entry, replacing the prior v3.5.3. This reflects a minor update to the page's version history rather than content changes.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA minor update to the ClinicalTrials.gov page’s revision/version indicator is shown (v3.5.2 → v3.5.3). This reflects a platform or release change rather than a change to the underlying trial record.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision 3.5.2 was added to the history and Revision 3.5.0 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded site revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the study history. This is an update to the page’s version history rather than to the trial data or content.SummaryDifference0.1%

- Check113 days agoChange DetectedVersion history shows a new revision v3.4.2 added and revision v3.4.1 removed, reflecting administrative updates to the record rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.